A new publication dated November 5, 2026 references vasoactive intestinal peptide in the context of gut physiology research. The study, titled "A Lactobacillus acidophilus LA15-Bifidobacterium animalis subsp. lactis Bi66 consortium alleviates loperamide-induced constipation by coordinating gut microbiota remodeling, mucosal barrier repair, and aquaporin-mediated water transport," appeared in the journal World Journal of Microbiology & Biotechnology.
The publication is indexed under PubMed ID 42986381. According to the available event data, the work focuses on a probiotic consortium and its relationship to gut microbiota remodeling, mucosal barrier repair, and aquaporin-mediated water transport in a loperamide-induced constipation model.
No specific findings, efficacy claims, or outcome data beyond the title and journal listing were provided with this event. This brief does not characterize or summarize results of the study beyond what is stated in the title itself.
Readers interested in the broader pharmacological and physiological context of vasoactive intestinal peptide can consult the compound overview for additional background.